New perspectives on the approach to chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 22, Issue 1-2, 1996, Pages 1-10

  Goodman, Michael G ^a   Spinosa, John C ^b   Saven, Alan ^a   Piro, Lawrence D ^a   Wormsley, Susan ^c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS MEMORIAL HOSPITAL   (United States)

^c BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; DNA; INTERLEUKIN 2; LOXORIBINE;

APOPTOSIS; B LYMPHOCYTE; CHEMOSENSITIVITY; CHRONIC LYMPHATIC LEUKEMIA; DNA SYNTHESIS; DRUG CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; IMMUNOSTIMULATION; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0029951793     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051723     Document Type: Review

References (51)

1. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. and Reed, J. C. (1993) bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820.
2. Buschle, M., Campana, D., Carding, S. R., Richard, C., Hoffbrand, A. V. and Brenner, M. K. (1993) Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med., 177, 213.
3. Foon, K. A., Rai, K. R. and Gale, R. P. (1990) Chronic lymphocytic leukemia: new insights into biology and therapy. Annals Int. Medicine, 113, 525.
4. Robert, K.-H., Moller, E., Garthon, G., Eriksson, H. and Nilsson, B. (1978) B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukemia. Clin. Exp. Immunol., 33, 302.
5. Fu, S. M., Winchester, R. J., Feizi, T., Walzer, P. D. and Kunkel, H. G. (1974) Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc. Natl Acad. Sci. USA, 71, 4487.
6. Robert, K.-H., Juliusson, G. and Biberfeld, P. (1983) Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytoma. Scand. J. Immunol., 17, 397.
7. Steinberg, J., Moore, M. A. S., Bernhardt, B., Bona, C. A. and Platsoucas, C. D. (1987) Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-μ and conditioned medium. Scand. J. Immunol., 25, 599.
8. Kinney, M. C., Collins, R. D., Whitlock, J., Cousar, J. B. and Vogler, L. B. (1989) Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA. Am. J. Pathol., 134, 913.
9. Carlsson, M., Matsson, P., Rosen, A., Sundstrom, C.,Totterman, T. H. and Nilsson, K. (1988) Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis. Leukemia, 2, 734.
10. Carlsson, M., Sundstrom, C., Bengtsson, M., Totterman, T. H., Rosen, A. and Nilsson, K. (1989) IL-4 strongly augments or inhibits DNA synthesis and differentiation of B-chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals, Eur. J. Immunol., 19, 913.
11. Cordingley, F. T., Bianchi, A., Hoffbrand, A. V., Reittie, J. E., Heslop, H. E., Vyakarnam, A.,Turner, M., Meager, A. and Brenner, M. K. (1988) Tumor necrosis factor as an autocrine tumor growth factor for chronic B cell malignancies. Lancet i, 969.
12. Hivroz, C., Grillot-Courvalin, C., Brouet, J. C. and Seligmann, M. (1986) Heterogeneity of responsiveness of chronic lymphocytic leukemia B cells to B cell growth factor or interleukjn 2. Eur. J. Immunol., 16, 1001.
13. Goodman, M. G. (1991) Cellular and biochemical studies of substituted guanine ribonucleoside immunostimulants. Immunopharmacol., 21, 51.
14. Bonnet, P. A. and Robins, R. K. (1993) Modulation of leukocyte genetic expression by novel purine nucleoside analogues. A new approach to tumor and antiviral agents. J. Med. Chem., 36, 635.
15. Goodman, M. G. and Weigle, W. O. (1983) Activation of lymphocytes by a thiol-derivatized nucleoside: Characterization of cellular parameters and responsive subpopulations. J. Immunol., 130, 551.
16. Goodman, M. G. and Hennen, W. J. (1986) Distinct effects of dual substitution on inductive and differentiative activities of C8-substituted guanine ribonucleosides. Cell, Immunol., 102, 395.
17. Ellis, T. M., Fisher, R. I., Bodner, B. and Anderson, D. W. (1990) Enhancement of human lymphokine activated killer cell induction by a guanosine ribonucleoside. Proc. Am. Ass. Cancer Res., 31, 280 (abstract 1661).
18. Goodman, M. G. (1995) A new approach to vaccine adjuvants: Immunopotentiation by intracellular T helper-like signals transmitted by loxoribine. In Vaccine Design: The Subunit Approach. M. F. Powell and M. J. Newman, eds. Plenum Publ. Corp., New York, p. 581.
19. Goodman, M. G. and Weigle, W. O. (1983) T cell-replacing activity of C8-derivatized guanine ribonucleosides. J. Immunol., 130, 2042.
20. Goodman, M. G. (1988) Induction of intcrleukin 1 activity from macrophages by direct interaction with C8-substiluted guanine ribonucleosides. Int. J. Immunopharmacol., 10, 579.
21. Goodman, M. G. (1987) Interaction between cytokines and 8-mercaptoguanosine in humoral immunity: Synergy with interferon. J. Immunol., 139, 142.
22. Pope, B. L., Chourmouzis, E., Lee, S. and Goodman, M. G. (1995) Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanosine ribonucleosides: Correlation with increased cytokine secretion. J. Immunotherapy, 17, 98.
23. Goodman, M. G. (1985) Demonstration of T-cell-dependent and T-cell independent components of 8-Mercaptoguanosine-mediated adjuvanticity. Proc. Soc. Exp. Biol. Med., 179, 479.
24. Goodman, M. G. and Weigle, W. O. (1986) Enhancement of T cell proliferation and differentiation by 8-mercaptoguanosine. In Purine and Pyrimidine Metabolism in Man V. W. L. Nyhan, L. F. Thompson and R. W. E. Watts, eds. Plenum Pub. Corp., p. 443.
25. Scheuer, W. V., Goodman, M. G., Parks, D. E. and Weigle, W. O. (1985) Active transformation of tolerogenic to immunogenic signals in T and B cells by 8-bromoguanosine. J. Immunol, 135, 2962.
26. Feldbush, T. L. and Ballas, Z. K. (1985) Lymphokine-like activity of 8-mercaptoguanosine: induction of T and B cell differentiation. J. Immunol., 134, 3204.
27. Thompson, R. A. and Ballas, Z. K. (1990) Lymphokine-activated killer (LAK) cells: V. 8-mercapatoguanosine as an IL-2 sparing agent in LAK generation. J. Immunol., 145, 3524.
28. Pope, B. L., Chourmouzis, E., MacIntyre, J. P., Lee, S. and Goodman, M. G. (1994) Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: Role of cytokines. Cell, Immunol, 159, 194.
29. Pope, B. L., Chourmouzis, E., Victorino, L., MacIntyre, J. P., Capetola, R. J. and Lau, C. Y. (1993) Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2. J. Immunol., 151, 3007.
30. Pope, B. L., Chourmouzis, E., Sigindere, J. and MacIntyre, J. P. (1993) In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine). Cell. Immunol., 147, 302.
31. Koo, G. C., Jewell, M. E., Manyak, C. L., Sigal, N. H. and Wicker, L. S. (1988) Activation of murine natural killer cells and macrophages by 8-bromoguanosine. J. Immunol., 140, 3249.
32. Pope, B. L., Sigindere, J., Chourmouzis, E., MacIntyre, P. and Goodman, M. G. (1994) 7-allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine. Cancer Immunol Immunother., 38, 83.
33. Goodman, M. G., Wormsley, S., Spinosa, J. C. and Piro, L. D. (1994) Loxoribine induces chronic lymphocytic leukemia B cells to traverse the cell cycle. Blood, 84(10), 3457.
34. Goodman, M. G. and Weigle, W. O. (1985) Enhancement of the human antibody response by C8-substituted guanine ribonucleosides in synergy with interleukin 2. J. Immunol, 135, 3284.
35. Dosch, H-M., Osundwa, V. and Lam, P. (1988) Activation of human B lymphocytes by 8'substituted guanosine derivatives, Immunol. Lett. 17, 125.
36. Rijkers, G. T., Dollekamp, I. and Zegers, B. J. M. (1988) 8-mercaptoguanosine overcomes unresponsiveness of human neonatal B cells to polysaccharide antigens. J. Immunoi. 141, 2313.
37. Totterman, T. H. and Nilsson, K. (1988) Differentiation of B-chronic lymphocytic leukemia cells in vitro, in Chronic Lymphocytic Leukemia. In. A. Polliack and D. Catovsky, eds. Harwood Acad., Chur, Switzerland, p. 353.
38. Totterman, T. H., Nilsson, K. and Sundstrom. C. (1980) Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature 288, 176.
39. Carlsson, M., Totterman, T. H., Rosen, A. and Nilsson, K. (1989) IL-2 and a T cell hybridoma (MP6) derived B cell stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells. Leukemia 3, 593.
40. Gordon, J., Mellstedt, H., Aman, P., Biberfeld, P. and Klein, G. (1984) Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens. J. Immunol. 132, 541.
41. Goodman, M. G., Reitz, A. B., Chen, R., Bobardt, M. D., Goodman, J. H. and Pope, B. L. (1995) Selective modulation of elements of the immune system by low molecular weight nucleosides. J. Pharmacol. Exp. Ther. 274, 1552.
42. Pope, B. L., MacIntyre, J. P., Kimball, E., Lee, S., Zhou, L., Gareth, R. and Goodman, M. G. (1995) The immunostimulatory compound 7-allyl-8-oxoguanosine (Loxonbine) induces a distinct subset of murine cytokines. Cell. Immunol. 162, 333.
43. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P. and Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795.
44. Hivroz, C., Geny, B., Brauet, J.-C. and Grillot-Courvalin, C. (1990) Altered signal transduction secondary to surface IgM cross-linking on B-chronic lymphocytic leukemia cells. J. Immunol. 144, 2351.
45. Michel, F., Merle-Beral, H., Legac, E., Michel, A., Debre P. and Bismuth, G. (1993) Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. J. Immunol. 150, 3624.
46. Bobardt, M. D., Goodman, J. H. and Goodman, M. G. (1995) B cell receptor-mediated signaling despite PTK disruption. The 9th International Congress of Immunology #4054, 683. (Abstract)
47. 2+]; elevation, phosphoinositide hydrolysis, and protein kinase C translocation. J. Biol. Chem. 265, 12248.
48. Buschle, M., Campana, D. and Carding, S. R. (1993) Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177, 213.
49. Uggla, C., Aguilar-Santelises, M., Rosen, A., Mellstedt, H. and Jondal, M. (1987) Spontaneous production of interleukin-1 activity by chronic lymphocytic leukemia cells. Blood 70, 1851.
50. Biondi, A., Rossi, V., Rassan, R., Barbui, T., Buttoni, S., Sironi, M., Mantovani, A. and Rambaldi, A. (1989) Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73, 1279.
51. Chaouchi, N., Tertian, G., Wallon, C., Taleb, J., Auffredou, M. T., Lemoine, F., Delfraissy, J. F. and Vasquez, A. (1993) Interferon α prevents in vitro apoptosis of chronic lymphocytic leukemia B cells. Blood 82, 391a. (Abstract)